Mechanistically, AC-AFPK-IsCT1 induces regulated cell death in tumor cells by increasing p53 and TNF-α levels, as well as caspases 8 and 3 levels, while downregulating the expression of proliferation markers PCNA and Cyclin D1. Here, TP53 is linked to neoplasm.